DM1

ARTHEx Biotech Reports ATX-01 DM1 Brain Therapy Progress

VALENCIA, Spain, July 23, 2026 ARTHEx Biotech has announced the publication of groundbreaking preclinical data demonstrating that its investigational...

By cGxPwire Editor
July 25, 2026

.Clinical

ARTHEx Biotech Advances ATX-01 for Myotonic Dystrophy

VALENCIA, Spain, May 27, 2026 ARTHEx Biotech, a clinical-stage biotechnology company focused on RNA-based therapeutics for neuromuscular diseases, has...

By cGxPwire Editor
May 28, 2026

Bio-Pharma

Sarepta Reports Breakthrough siRNA Data in FSHD, DM1

CAMBRIDGE, Massachusetts, March 25, 2026 Sarepta Therapeutics has announced first clinical data from its next-generation siRNA pipeline, demonstrating robust...